Search and Filter
Results per Page:
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Engineered HSV can trigger genetic chain reaction, rejigger HSV genes during co-infection
Proof-of-concept work raises hope that ‘gene drive’ could one day form basis of curative gene therapy for herpes
El momento en que se administra la TAR para el VIH es más importante de lo que imaginábamos
De los grupos de los doctores Edlefsen y Frenkel, Consorcio Oncológico
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
In the crosshairs: herpesvirus 6B as a potential cause of idiopathic pneumonia
From the Hill and Boeckh groups, Vaccine and Infectious Disease and Clinical Research Divisions
When a single amino acid makes all the difference
From the Geballe Lab, Human Biology Division
Switching from KSHV latency to lytic replication
From the Geballe lab, Human Biology Division & Cancer Consortium
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
A new take on having skin in the game
From the Zhu lab, Vaccine and Infectious Disease Division
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
What viruses can teach us about ourselves
Dr. Daphne Avgousti studies viruses that can give us a window into fundamental human biology that we can use to improve our health
A unique population of mucosal Tregs respond to local viral infection
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Sleuthing the immune system’s mysterious T-regs
Dr. Jennifer Lund probes why regulatory T cells show up when trouble comes around
Tissue localization shapes antiviral T cell dynamics
From the Prlic and Lund labs, Vaccine and Infectious Disease Division
B cell kinetics during HSV-2 infection
From the Corey lab, Vaccine and Infectious Disease Division
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer